Pharma-Biotech Product & Company Valuation
With Dr. Patrik Frei
Course Details
In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise:
High R&D Attrition Rates
Extended Investment Cycles
Complex IP Landscapes
This hands-on course equips you with practical valuation tools essential for:
Financing rounds and investment decisions
Mergers & acquisitions (M&A)
Licensing deals and partnerships
Strategic development planning
Portfolio optimisation
A Unique Learning Experience:
Expert-Led Instruction: Learn directly from a seasoned life science valuation specialist
Peer Learning: Connect with international peers facing similar challenges
Real-World Applications: Practice on actual case studies and industry scenarios
Join a select group of professionals who understand that accurate valuations are the foundation of successful deal-making in the pharma & biotech world.
Very well structured, introduced and explained. Patrik is an excellent speaker, perfectly combining theory and case studies. The organisation was great.
Noucor
Heidi Sisniega, Head Business Development & Licensing - Spain - September 2024
A methodology for assessing and optimising the risk profile of a life science company prior to valuation.
The different valuation methods used for life science companies and products.
How to calculate the value of a biotech or life science company with the Discounted Cash Flow method/rNPV, comparables and Venture Capital method.
How to use risk-adjusted Net Present Value (rNPV) to calculate the value of a pharmaceutical compound in development.
How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.
Excellent material and educator. Material was detailed, but explained at a great pace, even for a novice in finance.
Kinoxis Therapeutics
Raymond Luong, Business Development Associate - Australia - September 2024
To see the detailed agenda, please submit your details in the form below the table.
| Welcome (~30 min) |
| Introduction to Valuation: What – Why – When (~45 min) |
| How to Assess a Company Prior to Valuation (~30 min) |
| Valuation of Lifescience Companies: Methods - Dos & Don’ts (~1 h) |
| Group Work on a Company Valuation Case Study (~45 min) |
| Lunch Break |
| Product Valuation: The rNPV Calculation Method - Dos & Don’ts (~1 h) |
| From Valuation to Deal Structure (~30 min) |
| Group Work on a Product Valuation Case Study (~45 min) |
| Final Discussion & Wrap-up (~30 min) |
To see the detailed agenda, please submit your details in the form below:
Dr. Patrik Frei is Founder & CEO of Venture Valuation, specialists in independent assessments and valuation of emerging high-growth companies in biotechnology and life sciences.
He is Europe’s top valuation expert of high-growth life science companies and author of Assessment and Valuation of High Growth Companies.
Patrik and his team carried out valuations for the Novartis Venture Fund.
He is the owner of Biotechgate, the global business development database for the life science industry. Leave your details here for more information.
This is an introductory course and therefore very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries.
Would you like to receive a list of anonymised participant profiles from previous sessions?
The average Recommendation Score from participants of the last session was
8,8/10!
Read this selection of testimonials from recent participants:
Very well structured, introduced and explained. Patrik is an excellent speaker, perfectly combining theory and case studies. The organisation was great.
Noucor
Heidi Sisniega, Head Business Development & Licensing - Spain - September 2024
Excellent material and educator. Material was detailed, but explained at a great pace, even for a novice in finance.
Kinoxis Therapeutics
Raymond Luong, Business Development Associate - Australia - September 2024
The Product and Company Valuation course taught by Patrik Frei was an extremely valuable refresher with two very useful practical exercises.
Origent Data Sciences
David Ennist, CEO - USA - April 2024
A very well done course. It helped me to improve some aspects in companies and products evaluation.
Molteni Farmaceutici
Filippo Mannelli, Portfolio & Business Development Manager - Italy - April 2024
Well structured, well prepared and very clear content! Extremely professional and enlightening!
Basinnov LifeSciences
Vera Moura, Director - Portugal - April 2024
Thanks to Dr. Patrik Frei and his extremely clear and helpful course, valuation is now much clearer for me. I feel more confident to evaluate our future deals with biotech companies and look forward to meeting again soon with the peers I've met!
Laboratoires Expanscience
Philippine Furge, Business Development Project Manager - Spain - September 2023
This program was great for walking us through valuation and the different ways of thinking about it. It is easy to read text on valuation, but when you have someone you can ask questions to and then work through case studies, the learning experience is much better. Top marks all around for the content, the trainer and for the support from CELforPharma!
Canurta
Akeem Gardner, CEO - Canada - March 2023
A very valuable course which covered the different aspects to consider, as well as the most common valuation models used. The course brought both an excellent overview of the subject, as well as touched upon quite specific details in a way that was easy to follow. I particularly enjoyed learning from the experiences in the group and Patrik's very pedagogical presentation of a complex topic. I would highly recommend the course.
Gedea Biotech
Annette Säfholm, CEO - Sweden - March 2023
Patrik is an experienced and conscientious trainer, ensuring that everyone is following but still sticking to time. The case studies were particularly helpful and I leave feeling tooled-up for future real-world application.
Isogenica
Marion Cubitt, Director, Discovery - United Kingdom - March 2023
This session was well worth attending, very valuable. I enjoyed the discussions and the diversity of the group's backgrounds. Patrik is really amazing!
Novartis
Tamer Basha Elnaggar, Global Cell and Gene Pipeline Engagement Lead; Long Term Commercial & Pipeline Strategy - United States - March 2023
I highly recommend this course to folks interested in learning about valuation basics. Patrik did a great job at walking us through the basics of each topic but also addressing the more advanced questions in a way that beginners in valuation can also grasp. It was nice to get to know the other colleagues in biotech who attended the course and learn from each other’s experiences. Thank you Patrik. Thank you also to CELforPharma for their support. I really appreciate all the hard work put in for the impeccable communication and coordination before and during the course.
CCRM
Mohad Mehrabian, Technology & Venture Development - Canada - December 2022
Great course! It really perfected my knowledge in valuation. Many thanks to Patrik and CELforPharma for organising.
cells4therapy
Dirk Groenewegen, Managing Director - The Netherlands - December 2022
Super organisation and a friendly and experienced trainer made for a very valuable and enjoyable course. I finally have a plan on how to approach valuations. Thanks!
Universität für Bodenkultur Wien
Lisa-Ariadne Schmidt, Technology Transfer Manager - Austria - December 2022
The course materials were good, the content was excellent, the mentoring approach was good, and working with other people was great. I learned a lot about methods of assessing the valuation of Biotech companies. Very useful.
NeuroBioMat
Stéphane Woerly, President/Director Scientific - France - December 2022
I highly recommend CELforPharma online trainings as a fully professional place to improve your skills and industry knowledge.
Bioceltix
Andrij Włach, Proxy & CFO - Poland - September 2022
An excellent course for the foundation of valuation needed especially for those involved in due diligence activities from both the investor and investee side of the business.
CSL Behring
Joe Salazar, Global Senior Director Plasma Product Development CMC Lead - Switzerland - September 2022
High quality and concise information. Excellent delivery and well-balanced in-course work to capture the nuances.
Edinburgh Innovations
Lysimachos Zografos, Entrepreneur-in-Residence, Wellcome Programme Lead - United Kingdom - September 2022
The group had very interesting discussions and the basic parts of the valuation puzzle were clearly communicated!
Bay Pharma
Nilesh Vaghela, Managing Director - Germany - September 2022
A brilliant session to work through the key considerations of valuation and the importance of this.
Oxford University Innovation
Susan Campbell, Licensing and Ventures Manager - United Kingdom - September 2022
This course was excellent and well worth the 3:30 AM start time!
Sunovion Pharmaceuticals
Jason Newcom, Director, Business Development and Alliance Management - United States - November 2021
A useful course, both for beginners and more experienced people.
Fondazione Telethon
Annamaria Merico, Head of Business Development - Italy - November 2021
This is the 3rd course from CELforPharma I attended, and the impression is positive again. I can recommend their BD courses for both BD and non-BD functions, either for specific needs or just as a general introduction.
Binnopharm Group
Svetlana Bolsheva, Strategy & Business Development Director - Russian Federation - November 2021
This course was a great use of my time. Very informative from theory to practice!
Sunovion Pharmaceuticals
Michael Segal, Executive Director, Business Development and Alliance Management - United States - November 2021
This was a valuable course taught by an experienced professional. The course met my expectations in terms of acquiring concrete knowledge for business application.
AC BioScience
Christine Evans, Legal and Compliance - Spain - May 2021
Very effective, high impact and high engagement course with very professional coordination and presentation!
Jamjoom Pharma
Horia Vilcu, Business Development Director - Saudi Arabia - May 2021
This great course delivered professionalism, valid expertise, knowledge and tools ready to implement! Looking forward to part II and other courses.
Agrifirm
Nicole Fehrenbacher, Senior Innovation Scout - Belgium/Germany - May 2021
Very valuable to get some good insights in the challenges and mechanisms for valuation of pharma companies - highly recommended.
Let 'em know
Ola Bjorkman, CEO - Sweden - May 2021
The course provides valuation essentials and is a good first step into this topic. Everything was detailed enough to be beneficial, also if you already have some basic knowledge on this topic that you want to improve/reflect on. We got a useful overview regarding product/company valuation from Patrik, who presented the course with a high level of expertise and with excellent presentation skills.
Origimm Biotechnology
Florian Köck, Head of Finance & Business Operations - Austria - March 2021
This course was very comprehensive and Patrik Frei made some of the more complex notions very understandable, even for beginners in the field. I really enjoyed the case studies that allowed to apply the newly acquired notions in a practical way and helped a lot with understanding the more abstract ones. I came out with a better understanding and with practical tools that I can apply immediately in my every day work.
Immunic
Hames Mainka, Manager Business Development - Germany - March 2021
Very clear course set-up and content that covered the full scope of Product & Company valuation at the right level of detail. I really appreciated the valuable case studies as breakout exercises. The group interaction worked very well with Zoom and the day was well managed by the CELforPharma team. Thanks a lot!
GATT Technologies
Jasper Groenenboom, Director Strategy & Finance - The Netherlands - March 2021
I thought it was a well-designed course that met the requirements for my role and anyone working in a Business Development department. My most valuable take-aways from the day were the topics on company valuation, the assessment of risk strategy and the interesting case studies we worked on during the breakout group work sessions. The expert was highly skilled in presenting and showed a high level of expertise on each topic. There was also great communication and follow-up with CELforPharma before, during and after the course which added to an excellent online course experience.
Paladin Labs
Martin Noel, Manager Business Development - Canada - March 2021
A very clear course that can be appreciated whether you have a financial background or not.
AMC Biotech
Ariane Mansouri, Consultant - Germany - March 2021
Good overview of valuation methods, for both a biotech company or a product. Thanks!
Fyteko
Guillaume Wégria, CEO - Belgium - March 2021
3 April 2025
Live online (CET timing)
Early bird € 1 470
(Full fee € 1 670)
(until 28/02/2025)
25 September 2025
Live online (CET timing)
Early bird € 1 470
(Full fee € 1 670)
(until 22/08/2025)
Special Offer for Biotech Executives:
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
Important information:
Live online CET courses take place on Zoom between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
Live online EST courses take place on Zoom between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-face courses take place at a four-star business hotel close to the Brussels airport between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
You will receive all practical details after your registration.
For any questions related to the above, please do not hesitate to email Margherita Mutto or contact her by phone at +32 472 03 11 38 .
How to Register
Click the green "Register" button on the course session of your preference.
The registration wizard will guide you through the personal and company data that we need to process your registration.
You have the choice between 2 payment options:
Payment by credit card. You will not be required to pay immediately, but you will receive a secured payment link together with the invoice.
Payment via bank transfer
Click "Register Now". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.
For assistance with your registration, please email Annelies Swaan or contact her by phone at +32 486 98 52 49.
Included in the Registration Fee:
For live online courses:
Access to a virtual small-class (max 20 participants), expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats.
Course material will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course).
You will get a copy of the Excel-based valuation tool that is used during the course to gain practice in calculating the value of a phase II compound.
Certificate of attendance signed by the expert and CELforPharma.
For face-to-face courses:
Participation in a small-class (max 20 participants), expert led face-to-face course with interactive group exercises and plenary discussions. You will have the opportunity to meet the experts and discuss your own projects/issues during the breaks.
Course material will be provided to you in both digital format (by email) and in hard copy (so you can make notes during the course).
You will get a copy of the Excel-based valuation tool that is used during the course to gain practice in calculating the value of a phase II compound.
Opportunities for networking and informal discussions during coffee/tea breaks and lunch.
Certificate of attendance signed by the expert and CELforPharma.
Special Offer for Biotech Executives:
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
VAT Information
The prices on our website are excluding VAT. Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT.
We are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Group Discounts
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
Transfer & Cancellation Policy
Flexible Transfer
If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
Alternatively, the registrant can transfer once on a “space available” basis at no extra cost, until 3 weeks prior to the event, to another course of the same value held within one year of the original course date.
Registration Cancellation
Less than 14 days prior to the course date: registrant liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: registrant liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: registrant liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.
Benefits of CELforPharma’s face-to-face courses:
You have the unique opportunity to interact 1:1 with the expert(s).
Plenty of opportunity for informal 1:1 and group conversations with your international peers to exchange experiences and ideas, to discuss issues and to network.
Face-to-face interactions allow for more depth during Q&As and group work.
You can step away from your daily routine in the office and enjoy a more focused learning experience in a comfortable business hotel environment.
Benefits of CELforPharma’s live online courses:
The formal programme is as impactful as a face-to-face course thanks to the highly interactive format (using breakouts, polls, quizzes …).
No travel & accommodation expenses
You can attend the course from the comfort of your own office or home.
We send you the course materials by post so that you can take notes and fully engage with the course content.
No, if you choose credit card payment, we will send you a secure payment link together with the invoice.
Team discounts can be offered for 2 or more registrations confirmed at the same time. The level of discount will depend on the number of registrations and the availability of seats.
Email Annelies Swaan, Director Business Operations, for more details.
Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Our face-to-face courses in Brussels take place in four-star business hotels close to the airport. As part of our strong relationship with these hotels, CELforPharma has secured a discount on the daily room rate for our delegates who book their accommodation via us.
Upon your registration, we will assist you to make your hotel booking. For any assistance in this matter please do not hesitate to email Margherita Mutto, Course Coordinator, or contact her by phone at +32 472 03 11 38.
We do not record our live online public courses as we want to offer a safe environment for all attendees to share their experiences and freely ask questions.
This way, by participating in our courses, you do not only learn from our expert faculty but also from your international peers in the room.
No, we don't sell the course materials as a stand-alone.
Without the expert's explanation, the exercises and the discussions with other course participants, there is very little value in the slides.
Email Inge Cornelis, partner with CELforPharma, to help you choose the course that is best suited.
Yes!
We have helped many managers with setting up an in-house training programme for their team.
Email Inge Cornelis, partner with CELforPharma, to discuss your team training needs.
Do you have any other questions?
Email Annelies Swaan or call +32 486 98 52 49.
People attending this course are typically also interested in:
By clicking the below button, you will save this course to MY COURSES in the upper right corner of the website. This allows you to quickly retrieve it later.
Don’t forget to make a personal account using the Login button in the upper right corner of the website to keep your list of saved courses for your next visit.
Course Details
Upcoming Session
3 April 2025, Live online (CET timing)
Early bird € 1 470
(Full fee € 1 670)
(until 28/02/2025) Prices are excl. VAT
In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise:
High R&D Attrition Rates
Extended Investment Cycles
Complex IP Landscapes
This hands-on course equips you with practical valuation tools essential for:
Financing rounds and investment decisions
Mergers & acquisitions (M&A)
Licensing deals and partnerships
Strategic development planning
Portfolio optimisation
A Unique Learning Experience:
Expert-Led Instruction: Learn directly from a seasoned life science valuation specialist
Peer Learning: Connect with international peers facing similar challenges
Real-World Applications: Practice on actual case studies and industry scenarios
Join a select group of professionals who understand that accurate valuations are the foundation of successful deal-making in the pharma & biotech world.
Very well structured, introduced and explained. Patrik is an excellent speaker, perfectly combining theory and case studies. The organisation was great.
Noucor
Heidi Sisniega, Head Business Development & Licensing - Spain - September 2024
A methodology for assessing and optimising the risk profile of a life science company prior to valuation.
The different valuation methods used for life science companies and products.
How to calculate the value of a biotech or life science company with the Discounted Cash Flow method/rNPV, comparables and Venture Capital method.
How to use risk-adjusted Net Present Value (rNPV) to calculate the value of a pharmaceutical compound in development.
How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.
Excellent material and educator. Material was detailed, but explained at a great pace, even for a novice in finance.
Kinoxis Therapeutics
Raymond Luong, Business Development Associate - Australia - September 2024
To see the detailed agenda, please submit your details in the form below the table.
| Welcome (~30 min) |
| Introduction to Valuation: What – Why – When (~45 min) |
| How to Assess a Company Prior to Valuation (~30 min) |
| Valuation of Lifescience Companies: Methods - Dos & Don’ts (~1 h) |
| Group Work on a Company Valuation Case Study (~45 min) |
| Lunch Break |
| Product Valuation: The rNPV Calculation Method - Dos & Don’ts (~1 h) |
| From Valuation to Deal Structure (~30 min) |
| Group Work on a Product Valuation Case Study (~45 min) |
| Final Discussion & Wrap-up (~30 min) |
To see the detailed agenda, please submit your details in the form below:
Dr. Patrik Frei is Founder & CEO of Venture Valuation, specialists in independent assessments and valuation of emerging high-growth companies in biotechnology and life sciences.
He is Europe’s top valuation expert of high-growth life science companies and author of Assessment and Valuation of High Growth Companies.
Patrik and his team carried out valuations for the Novartis Venture Fund.
He is the owner of Biotechgate, the global business development database for the life science industry. Leave your details here for more information.
This is an introductory course and therefore very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries.
Would you like to receive a list of anonymised participant profiles from previous sessions?
The average Recommendation Score from participants of the last session was
8,8/10!
Read this selection of testimonials from recent participants:
Very well structured, introduced and explained. Patrik is an excellent speaker, perfectly combining theory and case studies. The organisation was great.
Noucor
Heidi Sisniega, Head Business Development & Licensing - Spain - September 2024
Excellent material and educator. Material was detailed, but explained at a great pace, even for a novice in finance.
Kinoxis Therapeutics
Raymond Luong, Business Development Associate - Australia - September 2024
The Product and Company Valuation course taught by Patrik Frei was an extremely valuable refresher with two very useful practical exercises.
Origent Data Sciences
David Ennist, CEO - USA - April 2024
A very well done course. It helped me to improve some aspects in companies and products evaluation.
Molteni Farmaceutici
Filippo Mannelli, Portfolio & Business Development Manager - Italy - April 2024
Well structured, well prepared and very clear content! Extremely professional and enlightening!
Basinnov LifeSciences
Vera Moura, Director - Portugal - April 2024
Thanks to Dr. Patrik Frei and his extremely clear and helpful course, valuation is now much clearer for me. I feel more confident to evaluate our future deals with biotech companies and look forward to meeting again soon with the peers I've met!
Laboratoires Expanscience
Philippine Furge, Business Development Project Manager - Spain - September 2023
This program was great for walking us through valuation and the different ways of thinking about it. It is easy to read text on valuation, but when you have someone you can ask questions to and then work through case studies, the learning experience is much better. Top marks all around for the content, the trainer and for the support from CELforPharma!
Canurta
Akeem Gardner, CEO - Canada - March 2023
A very valuable course which covered the different aspects to consider, as well as the most common valuation models used. The course brought both an excellent overview of the subject, as well as touched upon quite specific details in a way that was easy to follow. I particularly enjoyed learning from the experiences in the group and Patrik's very pedagogical presentation of a complex topic. I would highly recommend the course.
Gedea Biotech
Annette Säfholm, CEO - Sweden - March 2023
Patrik is an experienced and conscientious trainer, ensuring that everyone is following but still sticking to time. The case studies were particularly helpful and I leave feeling tooled-up for future real-world application.
Isogenica
Marion Cubitt, Director, Discovery - United Kingdom - March 2023
This session was well worth attending, very valuable. I enjoyed the discussions and the diversity of the group's backgrounds. Patrik is really amazing!
Novartis
Tamer Basha Elnaggar, Global Cell and Gene Pipeline Engagement Lead; Long Term Commercial & Pipeline Strategy - United States - March 2023
I highly recommend this course to folks interested in learning about valuation basics. Patrik did a great job at walking us through the basics of each topic but also addressing the more advanced questions in a way that beginners in valuation can also grasp. It was nice to get to know the other colleagues in biotech who attended the course and learn from each other’s experiences. Thank you Patrik. Thank you also to CELforPharma for their support. I really appreciate all the hard work put in for the impeccable communication and coordination before and during the course.
CCRM
Mohad Mehrabian, Technology & Venture Development - Canada - December 2022
Great course! It really perfected my knowledge in valuation. Many thanks to Patrik and CELforPharma for organising.
cells4therapy
Dirk Groenewegen, Managing Director - The Netherlands - December 2022
Super organisation and a friendly and experienced trainer made for a very valuable and enjoyable course. I finally have a plan on how to approach valuations. Thanks!
Universität für Bodenkultur Wien
Lisa-Ariadne Schmidt, Technology Transfer Manager - Austria - December 2022
The course materials were good, the content was excellent, the mentoring approach was good, and working with other people was great. I learned a lot about methods of assessing the valuation of Biotech companies. Very useful.
NeuroBioMat
Stéphane Woerly, President/Director Scientific - France - December 2022
I highly recommend CELforPharma online trainings as a fully professional place to improve your skills and industry knowledge.
Bioceltix
Andrij Włach, Proxy & CFO - Poland - September 2022
An excellent course for the foundation of valuation needed especially for those involved in due diligence activities from both the investor and investee side of the business.
CSL Behring
Joe Salazar, Global Senior Director Plasma Product Development CMC Lead - Switzerland - September 2022
High quality and concise information. Excellent delivery and well-balanced in-course work to capture the nuances.
Edinburgh Innovations
Lysimachos Zografos, Entrepreneur-in-Residence, Wellcome Programme Lead - United Kingdom - September 2022
The group had very interesting discussions and the basic parts of the valuation puzzle were clearly communicated!
Bay Pharma
Nilesh Vaghela, Managing Director - Germany - September 2022
A brilliant session to work through the key considerations of valuation and the importance of this.
Oxford University Innovation
Susan Campbell, Licensing and Ventures Manager - United Kingdom - September 2022
This course was excellent and well worth the 3:30 AM start time!
Sunovion Pharmaceuticals
Jason Newcom, Director, Business Development and Alliance Management - United States - November 2021
A useful course, both for beginners and more experienced people.
Fondazione Telethon
Annamaria Merico, Head of Business Development - Italy - November 2021
This is the 3rd course from CELforPharma I attended, and the impression is positive again. I can recommend their BD courses for both BD and non-BD functions, either for specific needs or just as a general introduction.
Binnopharm Group
Svetlana Bolsheva, Strategy & Business Development Director - Russian Federation - November 2021
This course was a great use of my time. Very informative from theory to practice!
Sunovion Pharmaceuticals
Michael Segal, Executive Director, Business Development and Alliance Management - United States - November 2021
This was a valuable course taught by an experienced professional. The course met my expectations in terms of acquiring concrete knowledge for business application.
AC BioScience
Christine Evans, Legal and Compliance - Spain - May 2021
Very effective, high impact and high engagement course with very professional coordination and presentation!
Jamjoom Pharma
Horia Vilcu, Business Development Director - Saudi Arabia - May 2021
This great course delivered professionalism, valid expertise, knowledge and tools ready to implement! Looking forward to part II and other courses.
Agrifirm
Nicole Fehrenbacher, Senior Innovation Scout - Belgium/Germany - May 2021
Very valuable to get some good insights in the challenges and mechanisms for valuation of pharma companies - highly recommended.
Let 'em know
Ola Bjorkman, CEO - Sweden - May 2021
The course provides valuation essentials and is a good first step into this topic. Everything was detailed enough to be beneficial, also if you already have some basic knowledge on this topic that you want to improve/reflect on. We got a useful overview regarding product/company valuation from Patrik, who presented the course with a high level of expertise and with excellent presentation skills.
Origimm Biotechnology
Florian Köck, Head of Finance & Business Operations - Austria - March 2021
This course was very comprehensive and Patrik Frei made some of the more complex notions very understandable, even for beginners in the field. I really enjoyed the case studies that allowed to apply the newly acquired notions in a practical way and helped a lot with understanding the more abstract ones. I came out with a better understanding and with practical tools that I can apply immediately in my every day work.
Immunic
Hames Mainka, Manager Business Development - Germany - March 2021
Very clear course set-up and content that covered the full scope of Product & Company valuation at the right level of detail. I really appreciated the valuable case studies as breakout exercises. The group interaction worked very well with Zoom and the day was well managed by the CELforPharma team. Thanks a lot!
GATT Technologies
Jasper Groenenboom, Director Strategy & Finance - The Netherlands - March 2021
I thought it was a well-designed course that met the requirements for my role and anyone working in a Business Development department. My most valuable take-aways from the day were the topics on company valuation, the assessment of risk strategy and the interesting case studies we worked on during the breakout group work sessions. The expert was highly skilled in presenting and showed a high level of expertise on each topic. There was also great communication and follow-up with CELforPharma before, during and after the course which added to an excellent online course experience.
Paladin Labs
Martin Noel, Manager Business Development - Canada - March 2021
A very clear course that can be appreciated whether you have a financial background or not.
AMC Biotech
Ariane Mansouri, Consultant - Germany - March 2021
Good overview of valuation methods, for both a biotech company or a product. Thanks!
Fyteko
Guillaume Wégria, CEO - Belgium - March 2021
3 April 2025
Live online (CET timing)
Early bird € 1 470
(Full fee € 1 670)
(until 28/02/2025)
25 September 2025
Live online (CET timing)
Early bird € 1 470
(Full fee € 1 670)
(until 22/08/2025)
Special Offer for Biotech Executives:
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
Important information:
Live online CET courses take place on Zoom between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
Live online EST courses take place on Zoom between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-face courses take place at a four-star business hotel close to the Brussels airport between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
You will receive all practical details after your registration.
For any questions related to the above, please do not hesitate to email Margherita Mutto or contact her by phone at +32 472 03 11 38 .
How to Register
Click the green "Register" button on the course session of your preference.
The registration wizard will guide you through the personal and company data that we need to process your registration.
You have the choice between 2 payment options:
Payment by credit card. You will not be required to pay immediately, but you will receive a secured payment link together with the invoice.
Payment via bank transfer
Click "Register Now". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.
For assistance with your registration, please email Annelies Swaan or contact her by phone at +32 486 98 52 49.
Included in the Registration Fee:
For live online courses:
Access to a virtual small-class (max 20 participants), expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats.
Course material will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course).
You will get a copy of the Excel-based valuation tool that is used during the course to gain practice in calculating the value of a phase II compound.
Certificate of attendance signed by the expert and CELforPharma.
For face-to-face courses:
Participation in a small-class (max 20 participants), expert led face-to-face course with interactive group exercises and plenary discussions. You will have the opportunity to meet the experts and discuss your own projects/issues during the breaks.
Course material will be provided to you in both digital format (by email) and in hard copy (so you can make notes during the course).
You will get a copy of the Excel-based valuation tool that is used during the course to gain practice in calculating the value of a phase II compound.
Opportunities for networking and informal discussions during coffee/tea breaks and lunch.
Certificate of attendance signed by the expert and CELforPharma.
Special Offer for Biotech Executives:
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
VAT Information
The prices on our website are excluding VAT. Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT.
We are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Group Discounts
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
Transfer & Cancellation Policy
Flexible Transfer
If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
Alternatively, the registrant can transfer once on a “space available” basis at no extra cost, until 3 weeks prior to the event, to another course of the same value held within one year of the original course date.
Registration Cancellation
Less than 14 days prior to the course date: registrant liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: registrant liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: registrant liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.
Benefits of CELforPharma’s face-to-face courses:
You have the unique opportunity to interact 1:1 with the expert(s).
Plenty of opportunity for informal 1:1 and group conversations with your international peers to exchange experiences and ideas, to discuss issues and to network.
Face-to-face interactions allow for more depth during Q&As and group work.
You can step away from your daily routine in the office and enjoy a more focused learning experience in a comfortable business hotel environment.
Benefits of CELforPharma’s live online courses:
The formal programme is as impactful as a face-to-face course thanks to the highly interactive format (using breakouts, polls, quizzes …).
No travel & accommodation expenses
You can attend the course from the comfort of your own office or home.
We send you the course materials by post so that you can take notes and fully engage with the course content.
No, if you choose credit card payment, we will send you a secure payment link together with the invoice.
Team discounts can be offered for 2 or more registrations confirmed at the same time. The level of discount will depend on the number of registrations and the availability of seats.
Email Annelies Swaan, Director Business Operations, for more details.
Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Our face-to-face courses in Brussels take place in four-star business hotels close to the airport. As part of our strong relationship with these hotels, CELforPharma has secured a discount on the daily room rate for our delegates who book their accommodation via us.
Upon your registration, we will assist you to make your hotel booking. For any assistance in this matter please do not hesitate to email Margherita Mutto, Course Coordinator, or contact her by phone at +32 472 03 11 38.
We do not record our live online public courses as we want to offer a safe environment for all attendees to share their experiences and freely ask questions.
This way, by participating in our courses, you do not only learn from our expert faculty but also from your international peers in the room.
No, we don't sell the course materials as a stand-alone.
Without the expert's explanation, the exercises and the discussions with other course participants, there is very little value in the slides.
Email Inge Cornelis, partner with CELforPharma, to help you choose the course that is best suited.
Yes!
We have helped many managers with setting up an in-house training programme for their team.
Email Inge Cornelis, partner with CELforPharma, to discuss your team training needs.
Do you have any other questions?
Email Annelies Swaan or call +32 486 98 52 49.
People attending this course are typically also interested in:
By clicking the below button, you will save this course to MY COURSES in the upper right corner of the website. This allows you to quickly retrieve it later.
Don’t forget to make a personal account using the Login button in the upper right corner of the website to keep your list of saved courses for your next visit.